News & Updates

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
28 Nov 2024

Individuals with worsening chronic kidney disease (CKD) are at greater risk for emergently treated hypocalcemia with denosumab, and the highest risk is observed among dialysis-dependent (DD) patients and those with CKD–mineral and bone disorder (CKD-MBD), reveals a study.

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
28 Nov 2024
BP control affected by COVID-19 pandemic
BP control affected by COVID-19 pandemic
28 Nov 2024

The COVID-19 pandemic had a negative impact on blood pressure (BP) control, as shown in a study using ambulatory BP monitoring (ABPM).

BP control affected by COVID-19 pandemic
28 Nov 2024